Altimmune Market Cap 2011-2026 | ALT

As of March 04, 2026 Altimmune has a market cap of $ 296 M

Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.^[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Altimmune

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
463 M	473 M	593 M	333 M	472 M	23.2 M	9.3 M	23.4 M	5.66 K	3.31 M	4.03 M	443 K	362 K	189 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
593 M	5.66 K	171 M

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.

Market Cap of other stocks in the Biotechnology industry

Issuer	Market Cap	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	2.77 B	$ 20.15	-2.68 %	$ 2.54 B	USA
MorphoSys AG MOR	315 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	4.09 M	$ 0.82	-3.48 %	$ 4.47 M	China
Axsome Therapeutics AXSM	8.67 B	$ 163.7	-1.61 %	$ 8.14 B	USA
I-Mab IMAB	127 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	33.6 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	549 M	-	-13.47 %	$ 169 M	France
AbCellera Biologics ABCL	962 M	$ 3.72	-2.75 %	$ 1.11 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	28.9 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	79 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	2.09 B	$ 8.52	-2.46 %	$ 1.39 B	Britain
Corvus Pharmaceuticals CRVS	94.1 M	$ 17.75	-0.79 %	$ 852 M	USA
Adverum Biotechnologies ADVM	76.4 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	2.83 B	-	-	-	Russia
Certara CERT	1.08 B	$ 7.16	1.49 %	$ 1.15 B	USA
ARCA biopharma ABIO	484 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	12.1 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	269 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	16.7 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	155 M	$ 25.91	-3.56 %	$ 694 M	USA
Acasti Pharma ACST	40.7 M	-	4.01 %	$ 150 M	Canada
Codexis CDXS	291 M	$ 0.99	-3.28 %	$ 72.7 M	USA
Catalyst Pharmaceuticals CPRX	3.04 B	$ 24.0	0.5 %	$ 2.93 B	USA
CureVac N.V. CVAC	3.53 B	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	41.4 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	14.1 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	724 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	32.8 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	19.6 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	215 K	$ 3.19	-4.64 %	$ 1.14 M	USA
Ayala Pharmaceuticals AYLA	7.72 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	3.25 B	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	1.63 B	$ 28.78	-1.44 %	$ 1.67 B	USA
Champions Oncology CSBR	106 M	$ 6.0	-1.15 %	$ 82 M	USA
Advaxis ADXS	1.87 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	172 M	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	661 M	-	-	-	Russia
Фармсинтез LIFE	2 B	-	-	-	Russia
Albireo Pharma ALBO	538 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	203 M	$ 3.67	-3.42 %	$ 116 M	France
Alector ALEC	247 M	$ 2.11	-4.75 %	$ 217 M	USA
KalVista Pharmaceuticals KALV	770 M	$ 15.68	-2.4 %	$ 779 M	Britain
Allena Pharmaceuticals ALNA	71.4 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	38.2 M	-	10.36 %	$ 9.8 M	USA
Teligent, Inc. TLGT	5.03 M	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	49 M	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	427 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	664 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	5.8 B	$ 14.27	2.44 %	$ 5.92 B	Irlanda